Thermostability/Infectivity Defect Caused by Deletion of the Core Protein V Gene in Human Adenovirus Type 5 Is Rescued by Thermo-selectable Mutations in the Core Protein X Precursor

Journal of Molecular Biology

Volumn 366, Issue 4, 2007, Pages 1142-1160

  Ugai, Hideyo ^a   Borovjagin, Anton V ^a   Le, Long P ^a   Wang, Minghui ^a   Curiel, David T ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

adenovirus; core proteins; Mastadenovirus; pV deletion; thermoselection

Indexed keywords

CORE PROTEIN; PROTEIN PRECURSOR; PROTEIN X; VIRUS PROTEIN V;

ARTICLE; BIOLOGICAL TRAIT; CONTROLLED STUDY; EVOLUTION; GENE DELETION; GENE ISOLATION; GENE MUTATION; GENE REPLICATION; GENE SEQUENCE; GENETIC CODE; HUMAN ADENOVIRUS 5; HYPOTHESIS; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POINT MUTATION; PRIORITY JOURNAL; THERMOSTABILITY; VIRION; VIRUS INFECTION;

ADENOVIRIDAE; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5; MAMMALIA; MASTADENOVIRUS;

EID: 33846847657     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.11.090     Document Type: Article

References (53)

1. Davison A.J., Benko M., and Harrach B. Genetic content and evolution of adenoviruses. J. Gen. Virol. 84 (2003) 2895-2908
2. Parks R.J. Adenovirus protein IX: a new look at an old protein. Mol. Ther. 11 (2005) 19-25
3. Bahr U., Schondorf E., Handermann M., and Darai G. Molecular anatomy of Tupaia (tree shrew) adenovirus genome; evolution of viral genes and viral phylogeny. Virus Genes 27 (2003) 29-48
4. Vellinga J., Van der Heijdt S., and Hoeben R.C. The adenovirus capsid: major progress in minor proteins. J. Gen. Virol. 86 (2005) 1581-1588
5. Rosa-Calatrava M., Grave L., Puvion-Dutilleul F., Chatton B., and Kedinger C. Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization. J. Virol. 75 (2001) 7131-7141
6. Lutz P., Rosa-Calatrava M., and Kedinger C. The product of the adenovirus intermediate gene IX is a transcriptional activator. J. Virol. 71 (1997) 5102-5109
7. Horwitz M.S. Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins. J. Gene Med. 6 Suppl. 1 (2004) S172-S183
8. Horwitz M.S. Adenovirus immunoregulatory genes and their cellular targets. Virology 279 (2001) 1-8
9. Tollefson A.E., Scaria A., Hermiston T.W., Ryerse J.S., Wold L.J., and Wold W.S. The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Virol. 70 (1996) 2296-2306
10. Tollefson A.E., Ryerse J.S., Scaria A., Hermiston T.W., and Wold W.S. The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants. Virology 220 (1996) 152-162
11. Suzuki K., Alemany R., Yamamoto M., and Curiel D.T. The presence of the adenovirus E3 region improves the oncolytic potency of conditionally replicative adenoviruses. Clin. Cancer Res. 8 (2002) 3348-3359
12. Sargent K.L., Meulenbroek R.A., and Parks R.J. Activation of adenoviral gene expression by protein IX is not required for efficient virus replication. J. Virol. 78 (2004) 5032-5037
13. Colby W.W., and Shenk T. Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX. J. Virol. 39 (1981) 977-980
14. Bett A.J., Krougliak V., and Graham F.L. DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309. Virus Res. 39 (1995) 75-82
15. Mittal S.K., Bett A.J., Prevec L., and Graham F.L. Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters. Virology 210 (1995) 226-230
16. Bett A.J., Prevec L., and Graham F.L. Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67 (1993) 5911-5921
17. Ghosh-Choudhury G., Haj-Ahmad Y., Brinkley P., Rudy J., and Graham F.L. Human adenovirus cloning vectors based on infectious bacterial plasmids. Gene 50 (1986) 161-171
18. Vayda M.E., Rogers A.E., and Flint S.J. The structure of nucleoprotein cores released from adenovirions. Nucl. Acids Res. 11 (1983) 441-460
19. Matthews D.A., and Russell W.C. Adenovirus core protein V is delivered by the invading virus to the nucleus of the infected cell and later in infection is associated with nucleoli. J. Gen. Virol. 79 (1998) 1671-1675
20. Chatterjee P.K., Vayda M.E., and Flint S.J. Interactions among the three adenovirus core proteins. J. Virol. 55 (1985) 379-386
21. van Oostrum J., and Burnett R.M. Molecular composition of the adenovirus type 2 virion. J. Virol. 56 (1985) 439-448
22. Lehmberg E., Traina J.A., Chakel J.A., Chang R.J., Parkman M., McCaman M.T., et al. Reversed-phase high-performance liquid chromatographic assay for the adenovirus type 5 proteome. J. Chromatog. ser. B, Biomed. Sci. Appl. 732 (1999) 411-423
23. Chatterjee P.K., Vayda M.E., and Flint S.J. Identification of proteins and protein domains that contact DNA within adenovirus nucleoprotein cores by ultraviolet light crosslinking of oligonucleotides 32P-labelled in vivo. J. Mol. Biol. 188 (1986) 23-37
24. Anderson C.W., Young M.E., and Flint S.J. Characterization of the adenovirus 2 virion protein, mu. Virology 172 (1989) 506-512
25. Matthews D.A. Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm. J. Virol. 75 (2001) 1031-1038
26. Shiomi H., Urasawa T., Urasawa S., Kobayashi N., Abe S., and Taniguchi K. Isolation and characterisation of poliovirus mutants resistant to heating at 50 degrees Celsius for 30 min. J. Med. Virol. 74 (2004) 484-491
27. Young C.S. Heat-stable variant of human adenovirus type 5: characterization and use in three-factor crosses. J. Virol. 15 (1975) 1168-1175
28. Chartier C., Degryse E., Gantzer M., Dieterle A., Pavirani A., and Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70 (1996) 4805-4810
29. Ensinger M.J., and Ginsberg H.S. Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus. J. Virol. 10 (1972) 328-339
30. Fried M. Isolation of temperature-sensitive mutants of polyoma virus. Virology 25 (1965) 669-671
31. Mofford L.M., and Marusyk R.G. Isolation and partial characterization of a human adenovirus type 4 temperature-sensitive mutant (Mastadenovirus h 4 tsl). Canad. J. Microbiol. 30 (1984) 135-141
32. Praszkier J., and Ginsberg H.S. Isolation and characterization of temperature-sensitive mutants of adenovirus type 7. J. Virol. 61 (1987) 3089-3095
33. Kauffman R.S., and Ginsberg H.S. Characterization of a temperature-sensitive, hexon transport mutant of type 5 adenovirus. J. Virol. 19 (1976) 643-658
34. Chee-Sheung C.C., and Ginsberg H.S. Characterization of a temperature-sensitive fiber mutant of type 5 adenovirus and effect of the mutation on virion assembly. J. Virol. 42 (1982) 932-950
35. Counago R., Chen S., and Shamoo Y. In vivo molecular evolution reveals biophysical origins of organismal fitness. Mol. Cell 22 (2006) 441-449
36. Anderson C.W., Hardy M.M., Dunn J.J., and Klessig D.F. Independent, spontaneous mutants of adenovirus type 2-simian virus 40 hybrid Ad2+ND3 that grow efficiently in monkey cells possess indentical mutations in the adenovirus type 2 DNA-binding protein gene. J. Virol. 48 (1983) 31-39
37. Aneskievich B.J., and Taichman L.B. Evidence for two points of restriction in the expression of adenovirus type 2 in cultured epidermal keratinocytes. J. Virol. 62 (1988) 4365-4368
38. Klessig D.F. Isolation of a variant of human adenovirus serotype 2 that multiplies efficiently on monkey cells. J. Virol. 21 (1977) 1243-1246
39. Yan W., Kitzes G., Dormishian F., Hawkins L., Sampson-Johannes A., Watanabe J., et al. Developing novel oncolytic adenoviruses through bioselection. J. Virol. 77 (2003) 2640-2650
40. Ugai H., Inabe K., Yamasaki T., Murata T., Obata Y., Hamada H., and Yokoyama K.K. Accumulation of infectious mutants in stocks during the propagation of fiber-modified recombinant adenoviruses. Biochem. Biophys. Res. Commun. 337 (2005) 806-814
41. Weber J.M., and Anderson C.W. Identification of the gene coding for the precursor of adenovirus core protein X. J. Virol. 62 (1988) 1741-1745
42. Lee T.W., Lawrence F.J., Dauksaite V., Akusjarvi G., Blair G.E., and Matthews D.A. Precursor of human adenovirus core polypeptide Mu targets the nucleolus and modulates the expression of E2 proteins. J. Gen. Virol. 85 (2004) 185-196
43. Hosokawa K., and Sung M.T. Isolation and characterization of an extremely basic protein from adenovirus type 5. J. Virol. 17 (1976) 924-934
44. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166 (1983) 557-580
45. Fallaux F.J., Kranenburg O., Cramer S.J., Houweling A., Van Ormondt H., Hoeben R.C., and Van Der Eb A.J. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7 (1996) 215-222
46. Kanegae Y., Makimura M., and Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 47 (1994) 157-166
47. Maizel Jr. J.V., White D.O., and Scharff M.D. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36 (1968) 115-125
48. Saito I., Oya Y., Yamamoto K., Yuasa T., and Shimojo H. Construction of non-defective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J. Virol. 54 (1985) 711-719
49. Ugai H., Watanabe S., Suzuki E., Tsutsui-Nakata H., Yokoyama K.K., and Murata T. Stability of a recombinant adenoviral vector: optimization of conditions for storage, transport and delivery. Jpn. J. Cancer Res. 93 (2002) 598-603
50. Shabram P., Vellekamp G., and Scandella C. Purification of adenovirus. In: Curiel D.T., and Douglas J.T. (Eds). Adenoviral Vectors for Gene Therapy (2002), Academic Press, London, UK 167-203
51. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
52. Tellefson A.E., Hermiston W.T., and Wold W.S.M. Preparation and itration of CsCl-banded adenovirus stock. In: Wold W.S.M. (Ed). Adenovirus Methods and Protocols (1999), Humana Press, Inc., Totowa, NJ 1-9
53. Ugai H., Yamasaki T., Hirose M., Inabe K., Kujime Y., Terashima M., et al. Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration. Biochem. Biophys. Res. Commun. 331 (2005) 1053-1060